申请人:Merck Sharp & Dohme, Limited
公开号:US05268378A1
公开(公告)日:1993-12-07
A class of 2,4-dioxo-1,2,3,4-tetrahydroquinoline derivatives, substituted at the 3-position by a range of carbonyl-containing substituents or by a five- or six-membered heteroaromatic moiety, are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA antagonist.
一类2,4-二氧代-1,2,3,4-四氢喹啉衍生物,其在3位被一系列含羰基取代基团或五元或六元杂芳基取代,是NMDA受体的选择性非竞争性拮抗剂和/或是AMPA受体的拮抗剂,因此在治疗神经退行性疾病、癫痫或精神分裂症等需要给予NMDA和/或AMPA拮抗剂的情况下具有实用价值。